At least 10% of medicines circulating worldwide are estimated to be falsified. In Africa, this figure is thought to reach 30% of the market, and up to 60 to 80% in conflict zones.
On the occasion of World Anti-Counterfeiting Day, the CFAO Group, through its CFAO Healthcare division, reaffirms its commitment to securing the medicine distribution network in Africa. As the leading pharmaceutical distributor on the Continent, CFAO Healthcare relies on robust infrastructure and proven expertise to support all stakeholders across the supply chain, from manufacturers to pharmacies and healthcare facilities.
Through our white paper co-published with the OPALS Foundation, CFAO Healthcare confirms its mission: securing access to quality medicines in Africa. This publication also reflects our desire to raise public awareness and call upon all stakeholders—governments, healthcare professionals, private actors, and civil society—to strengthen collaboration in service of supply chain security and the fight against illicit networks.
See also
